Live Analyst Rating Changes 34258 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Tania Armstrong-Whitworth
CG

Tania Armstrong-Whitworth

Wall Street Analyst
★★★☆☆
#1480
on 13Foresight · ranked by our own returns
69%
Success Rate
+10.6%
Average Return
9 of 13 calls profitable · +45.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 69% of Tania Armstrong-Whitworth's ratings turned a profit when each position was held for 1 year — averaging +10.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

10 Buy 3 Hold 0 Sell
Tania's Stock Coverage 17 ratings · 2026-09-24
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TSE:NURS
Hydreight Technologies Inc
Sep 02, 2026 BUY Strong Buy
+154.1% avg upside
2 analysts
$6.75
117.81% Upside
· ·
TSE:DMGI
DMG Blockchain Solutions
Aug 27, 2026 HOLD Buy
+23.6% avg upside
4 analysts
$0.55
1.87% Downside
· ·
TSE:JWEL
Jamieson Wellness Inc
Aug 10, 2026 HOLD Strong Buy
-9.1% avg upside
11 analysts
$45.75
0.71% Upside
+0.1% ·
TSE:APTX
Apotex Health Corp.
Jul 13, 2026 BUY Strong Buy
+21.6% avg upside
12 analysts
$42.00
24.80% Upside
-11.7% ·
TSE:MSCL
Satellos Bioscience
May 21, 2026 BUY Strong Buy
+147.3% avg upside
8 analysts
$19.00
56.16% Upside
+32.6% ·
TSE:HLS
HLS Therapeutics Inc
May 19, 2026 HOLD Strong Buy
+107.2% avg upside
5 analysts
$5.00
26.52% Upside
-13.7% ·
TSE:GUD
Knight Therapeutics
May 08, 2026 BUY Strong Buy
-9.1% avg upside
8 analysts
$9.50
5.83% Downside
+17.9% ·
TSE:EXE
Extendicare
Dec 04, 2025 BUY Strong Buy
-12.7% avg upside
9 analysts
$22.50
29.39% Downside
+39.8% ·
TSE:BTCT
Bitcoin Treasury Corporation
Nov 14, 2025 BUY Strong Buy
+201.6% avg upside
1 analyst
$12.25
201.63% Upside
· ·
TSE:EPRX
Eupraxia Pharmaceuticals
Sep 02, 2025 BUY Strong Buy
+85.6% avg upside
11 analysts
$9.00
21.34% Downside
+37.3% ·
TSE:CPH
Cipher Pharmaceuticals
Aug 11, 2025 HOLD Strong Buy
-32.7% avg upside
5 analysts
$14.00
1.90% Downside
+19.3% ·
TSE:DHT.UN
DRI Healthcare
Nov 05, 2024 BUY Strong Buy
+16.3% avg upside
8 analysts
$19.50
7.51% Upside
+15.6% ·
TSE:CRRX
CareRx
Aug 08, 2024 BUY Strong Buy
+60.3% avg upside
6 analysts
$3.50
10.67% Upside
+27.1% ·
TSE:MDP
Medexus Pharmaceuticals Inc
Jul 04, 2024 BUY Strong Buy
+1.0% avg upside
6 analysts
$2.65
47.75% Downside
+47.4% ·
BABYF
Else Nutrition Holdings
Nov 15, 2023 HOLD Hold
+167.3% avg upside
1 analyst
$0.32
167.32% Upside
· ·
DFTX
Definium Therapeutics
Nov 21, 2022 BUY Strong Buy
+39.2% avg upside
23 analysts
$18.00
52.17% Downside
-1.5% ·
TSE:BU
Burcon Nutrascience
Jun 28, 2022 BUY Strong Buy
+320.7% avg upside
2 analysts
$3.00
139.90% Upside
-72.0% ·
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Tania Armstrong-Whitworth — Frequently Asked Questions
How accurate are Tania Armstrong-Whitworth's stock ratings?
Based on the calls 13Foresight could measure, about 69% of Tania's ratings were profitable over a one-year hold, with an average return of +10.6% per rating, or +45.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Tania ranked on 13Foresight?
Tania Armstrong-Whitworth is currently ranked #1480 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Tania cover?
Tania most recently has ratings on TSE:NURS, TSE:DMGI, TSE:JWEL, TSE:APTX, TSE:MSCL, TSE:HLS, TSE:GUD, TSE:EXE, TSE:BTCT, TSE:EPRX, TSE:CPH, TSE:DHT.UN and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.